Movement Science/Human Performance Laboratory, Montana State University, Bozeman, MT, USA.
Int J Med Sci. 2011 Mar 2;8(3):192-7. doi: 10.7150/ijms.8.192.
Confusion and controversy exist regarding the cardiovascular effects of dietary supplements containing caffeine and Citrus aurantium (bitter orange) extract. The primary protoalkaloidal ingredient in bitter orange extract is p-synephrine which has some structural similarities to ephedrine and nor-epinephrine, but exhibits markedly different pharmacokinetic and receptor binding properties. The goal of this study was to investigate the cardiovascular effects of a product containing caffeine, bitter orange extract (p-synephrine) and green tea extract in mildly overweight individuals. Fourteen female and nine male subjects (age 24.7 ±7.4 yrs, BMI: 26.6 ±3.8) volunteered in this randomized, placebo-controlled, crossover, double-blind designed study. On day one, subjects entered the laboratory following an overnight fast. Heart rate and blood pressure were recorded at 60 min. Expired air was analyzed for the next 10 min of the session. At each of three meals, subjects ingested one capsule that was either a non-caloric placebo or a dietary supplement that contained 13 mg p-synephrine and 176 mg caffeine. On the following day, the subjects returned and repeated the protocol for data collection beginning 60 min after consuming one capsule of the placebo or the dietary supplement. No effects of the dietary supplement on heart rate, systolic and diastolic blood pressure or mean arterial pressure were observed. No between or within group differences were observed when data were analyzed for gender and caffeine usage. A small but significant decrease in resting respiratory exchange ratio was observed for the low caffeine user group in response to the product containing caffeine and p-synephrine. The results of this study indicate that ingestion of a product containing bitter orange extract, caffeine and green tea extract does not lead to increased cardiovascular stress and that fat oxidation may increase in certain populations.
关于含咖啡因和枳实(酸橙)提取物的膳食补充剂对心血管的影响,存在着困惑和争议。枳实提取物的主要原生物碱成分是对羟福林,它与麻黄碱和去甲肾上腺素有些结构相似,但表现出明显不同的药代动力学和受体结合特性。本研究的目的是研究含有咖啡因、枳实提取物(对羟福林)和绿茶提取物的产品对超重个体的心血管影响。14 名女性和 9 名男性受试者(年龄 24.7±7.4 岁,BMI:26.6±3.8)参与了这项随机、安慰剂对照、交叉、双盲设计的研究。第一天,受试者在禁食过夜后进入实验室。在 60 分钟时记录心率和血压。在会议的下一个 10 分钟内分析呼出的空气。在每餐中,受试者都服用一粒胶囊,要么是无热量安慰剂,要么是含有 13 毫克对羟福林和 176 毫克咖啡因的膳食补充剂。第二天,受试者返回并重复该方案,在服用安慰剂或膳食补充剂胶囊后 60 分钟开始收集数据。膳食补充剂对心率、收缩压和舒张压或平均动脉压没有影响。当按性别和咖啡因使用情况分析数据时,没有观察到组间或组内差异。在低咖啡因使用者组中,休息时呼吸交换率有一个小但显著的下降,这是对含有咖啡因和对羟福林的产品的反应。本研究的结果表明,摄入含有枳实提取物、咖啡因和绿茶提取物的产品不会导致心血管压力增加,并且在某些人群中脂肪氧化可能会增加。